Beam Therapeutics (BEAM) stock falls as patient dies after receiving the company's gene editing therapy.in an early-stage ...
BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...
Beam Therapeutics enrolls 35 patients in BEACON trial for BEAM-101 in sickle cell disease, with promising early safety and ...
The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...
BEAM-101 is an ex vivo genetic therapy delivered as part of an autologous haematopoietic stem cell transplant (HSCT) after a ...
The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of ...
Veterans Day 2024 has revived interest in what was at one time Gerstner Field, one of the largest of the 28 Aviation Signal ...
The company Haiku Houses designed the post-and-beam structure reminiscent of a 16th century Japanese country house.
Analysts estimate that Beam Therapeutics will report an earnings per share (EPS) of $-1.16. The announcement from Beam Therapeutics is eagerly anticipated, with investors seeking news of surpassing ...
Israeli officials describe the Iron Beam system as being designed to work in tandem with existing air defense platforms such ...
Originally slated for this year, system uses lasers to intercept rockets and drones for a fraction of the cost of the Iron ...
Israel’s new air defense system, the Iron Beam, will be integrated into the country’s network within a year, the Ministry of ...